The percentages of elevated results (diagnostic sensitivity) of CXCR4 (80%) were higher than those of CXCL12 (47%) and much higher than classical tumor markers—CEA (22%) and SCC-Ag (14%) as well as CRP (57%). This evidence concerns the gene CXCL12 and neoplasm.